Actuate Therapeutics ACTU
NASDAQ ACTU
$0.76 +0.07 (+10.28%)
As of: Sep 30, 2026 · 12:43 PM EDT

Actuate Therapeutics, Inc. (ACTU) Common Equity (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) recorded Common Equity of $989,152 in Q2 2026, compared with -$2.65 million a year earlier.

Analysis

Actuate Therapeutics, Inc. (ACTU) Common Equity (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics reported Common Equity of $7.92 million.

  • Across earlier years, Common Equity came in at $104,186 in FY2024 and -$99.63 million in FY2023.
  • Quarterly Common Equity has ranged from -$114.26 million in Q2 2024 to $10.94 million in Q3 2025 over the past five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 989,152.00
Dec 31, 2025 7.92 Mn
Sep 30, 2025 10.94 Mn
Jun 30, 2025 -2.65 Mn
Mar 31, 2025 -5.09 Mn
Dec 31, 2024 104,186.00
Sep 30, 2024 5.36 Mn
Jun 30, 2024 -114.26 Mn
Mar 31, 2024 -107.77 Mn
Dec 31, 2023 -99.63 Mn
Sep 30, 2023 -92.14 Mn
Jun 30, 2023 -85.95 Mn
API Access

Actuate Therapeutics, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ACTU&period=max&api_key=YOUR_API_KEY